Trupanion, Inc. (TRUP) stock
TRUPNasdaqHospital & Medical Service PlansFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3051% above fair value
$34.48+0.18 (+0.52%)
Close on Nov 13, 2026Market cap $1.51BP/E 56.5Yield –
Trupanion r&d expenses
Research and development expenses are spending on new products and technology.
For fiscal 2014 it was $9.90M, up 102.5% from the year before.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | $9.90M | +102.5% |
| FY2013 | Dec 31, 2013 | $4.89M | +43.5% |
| FY2012 | Dec 31, 2012 | $3.41M | – |
See a number that looks wrong?